{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:51Z","timestamp":1786985031332,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002975","name":"Dainippon Sumitomo Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bbr.2022.113883","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T11:23:13Z","timestamp":1649244193000},"page":"113883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Risperidone on apomorphine-induced stereotyped behavior and auditory sensory gating in rhesus monkeys"],"prefix":"10.1016","volume":"428","author":[{"given":"Yoshihiro","family":"Iwamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokazu","family":"Nakako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Katsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2022.113883_bib1","first-page":"1","article-title":"Input dysfunction in schizophrenia","volume":"72","author":"Venables","year":"1963","journal-title":"Prog. Exp. Pers. Res."},{"issue":"4","key":"10.1016\/j.bbr.2022.113883_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/schbul\/13.4.669","article-title":"Neurobiological studies of sensory gating in schizophrenia","volume":"13","author":"Freedman","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"12","key":"10.1016\/j.bbr.2022.113883_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1001\/archpsyc.1996.01830120052009","article-title":"Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects: human recordings, computer simulation, and an animal model","volume":"53","author":"Freedman","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113883_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1566-2772(03)00018-5","article-title":"Sensory gating deficits in schizophrenia: can we parse the effects of medication, nicotine use, and changes in clinical status?","volume":"3","author":"Light","year":"2003","journal-title":"Clin. Neurosci. Res."},{"key":"10.1016\/j.bbr.2022.113883_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.psychres.2007.02.009","article-title":"P50 sensory gating ratios in schizophrenia and controls: a review and data analysis","volume":"158","author":"Patterson","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbr.2022.113883_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.schres.2009.05.019","article-title":"Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients","volume":"113","author":"Boutros","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbr.2022.113883_bib7","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/j.1469-8986.2011.01262.x","article-title":"An evaluation of P50 paired-click methodologies","volume":"48","author":"Dalecki","year":"2011","journal-title":"Psychophysiology"},{"key":"10.1016\/j.bbr.2022.113883_bib8","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/sj.npp.1300841","article-title":"Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats","volume":"31","author":"Swerdlow","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2022.113883_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.2044-8341.1961.tb00936.x","article-title":"Disorders of attention and perception in early schizophrenia","volume":"34","author":"McGhie","year":"1961","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.bbr.2022.113883_bib10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0006-3223(86)90244-1","article-title":"Neurophysiological studies of sensory gating in rats: Effects of amphetamine, phencyclidine, and haloperidol","volume":"21","author":"Adler","year":"1986","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113883_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0920-9964(98)00075-9","article-title":"P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention","volume":"33","author":"Erwin","year":"1998","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbr.2022.113883_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.psychres.2005.11.002","article-title":"Prepulse inhibition and P50 suppression: commonalities and dissociations","volume":"143","author":"Oranje","year":"2006","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbr.2022.113883_bib13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/schbul\/sbr034","article-title":"The development of neural synchrony and large-scale cortical networks during adolescence: relevance for the pathophysiology of schizophrenia and neurodevelopmental hypothesis","volume":"37","author":"Uhlhaas","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbr.2022.113883_bib14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.biopsych.2008.02.006","article-title":"Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients","volume":"64","author":"Brockhaus-Dumke","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113883_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1176\/appi.ajp.2017.16111203","article-title":"Clinical and cognitive significance of auditory sensory processing deficits in schizophrenia","volume":"175","author":"Hamilton","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113883_bib16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.neubiorev.2004.06.003","article-title":"Meta-analysis and the sciences of schizophrenia: variant evidence or evidence of variants?","volume":"28","author":"Heinrichs","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2022.113883_bib17","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/schbul\/sbj050","article-title":"Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia","volume":"32","author":"Potter","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbr.2022.113883_bib18","doi-asserted-by":"crossref","unstructured":"Bramon E., Rabe-Hesketh S., Sham P., Murray R.M., Frangou S., Meta-analysis of the P300 and P50 waveforms in schizophrenia, Schizophr. Res. 2004; 70, pp. 315\u2013329.","DOI":"10.1016\/j.schres.2004.01.004"},{"key":"10.1016\/j.bbr.2022.113883_bib19","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased bassline occupancy of D2 receptors by dopamine in schizophrenia","volume":"97","author":"Abi-Dargham","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbr.2022.113883_bib20","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s007020100021","article-title":"An increase in [3H] SCH23390 binding in the cerebral cortex of postmortem brains of chronic schizophrenics","volume":"108","author":"Domyo","year":"2001","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbr.2022.113883_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archgenpsychiatry.2009.176","article-title":"Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia","volume":"67","author":"Rasmussen","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbr.2022.113883_bib22","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1007\/BF02245005","article-title":"Differential changes in serotonin 5-HT1A and 5-HT2 receptor binding in patients with chronic schizophrenia","volume":"112","author":"Hashimoto","year":"1993","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.bbr.2022.113883_bib23","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0006-3223(99)00034-7","article-title":"Amphetamine disrupts P50 suppression in normal subjects","volume":"46","author":"Light","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.bbr.2022.113883_bib24","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.parkreldis.2015.06.012","article-title":"Expert consensus group report on the use of apomorphine in the treatment of parkinson\u2019s disease\u2014clinical practice recommendations","volume":"21","author":"Trenkwalder","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.bbr.2022.113883_bib25","doi-asserted-by":"crossref","unstructured":"Chaudhuri K.R.L., Rizos A., Sethi K.D., Motor and nonmotor complications in Parkinson\u2019s disease: an argument for continuous drug delivery? J Neural Transm (Vienna). 2013; 120, 9, pp. 1305\u20131320.","DOI":"10.1007\/s00702-013-0981-5"},{"issue":"2","key":"10.1016\/j.bbr.2022.113883_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40268-018-0230-3","article-title":"The many faces of apomorphine: lessons from the past and challenges for the future","volume":"18","author":"Manon","year":"2018","journal-title":"Drugs R. D."},{"key":"10.1016\/j.bbr.2022.113883_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0920-9964(99)00138-3","article-title":"Xanomeline, an M(1)\/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice","volume":"42","author":"Shannon","year":"2000","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.bbr.2022.113883_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00421901","article-title":"Apomorphine provoked stereotypy in the dog","volume":"26","author":"Nymark","year":"1972","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2022.113883_bib29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0074-7742(08)60705-9","article-title":"Apomorphine: chemistry, pharmacology, biochemistry","volume":"19","author":"Colpaert","year":"1976","journal-title":"Int. Rev. Neurobiol."},{"issue":"1","key":"10.1016\/j.bbr.2022.113883_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbr.2011.12.042","article-title":"Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: evidence that at a very low dose haloperidol acts as an indirect dopamine agonist","volume":"229","author":"Dias","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"1\u20133","key":"10.1016\/j.bbr.2022.113883_bib31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejphar.2008.08.011","article-title":"Apomorphine-induced emesis in dogs: differential sensitivity to established and novel dopamine D2\/5-HT(1A) antipsychotic compounds","volume":"597","author":"Depoort\u00e8re","year":"2008","journal-title":"Eur. J. Pharm."},{"issue":"6","key":"10.1016\/j.bbr.2022.113883_bib32","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/sj.npp.1300151","article-title":"The muscarinic M1\/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys","volume":"28","author":"Andersen","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.bbr.2022.113883_bib33","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/BF02244986","article-title":"Plasma protein binding of risperidone and its distribution in blood","volume":"114","author":"Mannens","year":"1994","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2022.113883_bib34","first-page":"685","article-title":"Pharmacology of Risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties","volume":"244","author":"Janssen","year":"1988","journal-title":"J. Pharm. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bbr.2022.113883_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881114563634","article-title":"Glutamate and dopamine in schizophrenia: an update for the 21st century","volume":"29","author":"Howes","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2022.113883_bib36","first-page":"782","article-title":"The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat","volume":"299","author":"Stanhope","year":"2001","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.bbr.2022.113883_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-2999(78)90251-0","article-title":"Climbing behavior induced by apomorphine in mice: a potential model for the detection of neuroleptic activity","volume":"50","author":"Costall","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2022.113883_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00431987","article-title":"Interaction of apomorphine and haloperidol: Effects on locomotion and other behavior in the marmoset","volume":"66","author":"Scraggs","year":"1979","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2022.113883_bib39","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/ilar\/ilu016","article-title":"Stereotypic behavior in nonhuman primates as a model for the human condition","volume":"55","author":"Lutz","year":"2014","journal-title":"ILAR J."},{"key":"10.1016\/j.bbr.2022.113883_bib40","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.neuropharm.2016.01.029","article-title":"Nicotinic acetylcholine receptor-mediated GABAergic inputs to cholinergic interneurons in the storiosomes and the matrix compartments of the mouse striatum","volume":"105","author":"Inoue","year":"2016","journal-title":"Neuropharmacology"},{"issue":"Issue 1","key":"10.1016\/j.bbr.2022.113883_bib41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0306-4522(92)90388-I","article-title":"Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum","volume":"50","author":"Hu","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2022.113883_bib42","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.109.162123","article-title":"Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin-and apomorphine-induced disruptions of prepulse inhibition: Involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors","volume":"333","author":"Gogos","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2022.113883_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-8993(91)90864-R","article-title":"Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating","volume":"555","author":"Stevens","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2022.113883_bib44","doi-asserted-by":"crossref","unstructured":"Thwaites S.J., Gogos A., van den Buuse M., Schizophrenia-like disruptions of sensory gating by serotonin receptor stimulation in rats: Effects of MDMA, DOI and 8-OH-DPAT, Pharmacol. Biochem. Behav. 2013; 112, pp. 71\u201377. doi: 10.1016\/j.pbb.2013.09.016.","DOI":"10.1016\/j.pbb.2013.09.016"},{"key":"10.1016\/j.bbr.2022.113883_bib45","doi-asserted-by":"crossref","unstructured":"Scarlota L.C., Harvey J.A., Aloyo V.J., The role of serotonin-2 (5-HT2) and dopamine receptors in the behavioral actions of the 5-HT2A\/2C agonist, DOI, and putative 5-HT2C inverse agonist, SR46349B, Psychopharmacology 2011; 213, pp. 393\u2013401. doi: 10.1007\/s00213\u2013010-1928\u20132.","DOI":"10.1007\/s00213-010-1928-2"},{"key":"10.1016\/j.bbr.2022.113883_bib46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pbb.2011.12.002","article-title":"Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (+\/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD)","volume":"101","author":"Schindler","year":"2012","journal-title":"Pharm., Biochem. Behav."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432822001516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432822001516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T04:22:29Z","timestamp":1716351749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432822001516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":46,"alternative-id":["S0166432822001516"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2022.113883","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risperidone on apomorphine-induced stereotyped behavior and auditory sensory gating in rhesus monkeys","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2022.113883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113883"}}